4//SEC Filing
PIERIS PHARMACEUTICALS, INC. 4
Accession 0000899243-15-003512
$PVLACIK 0001583648operating
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:08 PM ET
Size
5.6 KB
Accession
0000899243-15-003512
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2015-08-17+500,000→ 500,000 totalExercise: $3.36Exp: 2025-08-17→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on August 17, 2016 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until August 17, 2019.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001583648
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:08 PM ET
- Size
- 5.6 KB